Innovation in Medicine, Episode 5: Lanny Kirsch скачать в хорошем качестве

Innovation in Medicine, Episode 5: Lanny Kirsch

In this video, we have a conversational in-depth discussion about MRD testing in myeloma. Dr. Kirsch is the Senior Vice President for Medical Research at Adaptive Biotechnologies. https://www.adaptivebiotech.com/ He received his M.D. from Harvard University Medical School and subsequently completed Residency at Children’s Hospital Medical Center, Boston, Massachusetts and Fellowship in Pediatric Hematology/Oncology at the National Cancer Institute (NCI) in Bethesda, Maryland. He completed a three-year postdoctoral fellowship in molecular genetics in the laboratory of Dr. Philip Leder at the National Institute of Child Health and Human Development. Subsequently, he spent over 20 years at the NCI as a basic researcher, attending physician in the Pediatric Branch and Cancer Genetics Service and, ultimately, Chief of the Genetics Branch within the Center for Cancer Research. His research interests have been focused on the structure and function of the immunoglobulin and T-cell receptor genes and the use of probes from those loci to study cancer specific genetic instability and cancer genetics. In 2005, he joined the biotech/pharma company, Amgen, as an Executive Director heading the Oncology Research group at Amgen Washington in Seattle. He has been an independent consultant to the biotech/pharma industry with extended assignments focused on the development of antibody therapeutics and molecular diagnostics. He currently serves as the Senior Vice President of Translational Medicine, Adaptive Biotechnologies, Seattle, Washington (www.adaptivebiotech.com). He is the author of more than 160 peer-reviewed manuscripts and over 30 books, chapters, or reviews.